U.S. Infrastructure Stock News

Event driven interest in Medtronic stock Medtronic (MDT) is back in focus after reporting its strongest annual revenue growth in a decade, with fourth quarter revenue up 9.9% year over year and cardio sales showing especially strong momentum. Investors are weighing how this performance, combined with rapid uptake of PulseSelect and the Affera System and a competitively priced Hugo surgical robot, compares with recent share price weakness and cautious margin commentary. See our latest analysis...

United States Antimony (NYSE:UAMY) has appointed Sadler Gibb & Associates, LLC as its new independent registered public accounting firm. The change follows the acquisition of the company’s former auditor, Assure CPA, LLC, by Sadler Gibb & Associates, LLC. The audit engagement team is expected to remain in place under the new firm, providing continuity in the company’s audit process. United States Antimony, which focuses on antimony and related mineral products, now faces a fresh layer of...

With the S&P 500 trading on a forward P/E of 21.1 versus a 10 year average of 18.9, rich valuations, heavy AI expectations and a concentrated technology sector are leaving many investors wondering where to find steadier ground. This is where low volatility stocks can become interesting, especially when inflation is still above the Fed’s 2% target and further rate moves are on the table. Below, three stocks from a low volatility screener, all exposed to these market drivers in different ways,...

Evergy recently reported a 25.5% rise in adjusted first-quarter earnings per share and signed an electric service agreement supporting a large project in its Kansas Central service territory, while institutional ownership climbed to 93.50% as major investors like BlackRock and State Street increased their stakes. Analysts now assign Evergy strong buy ratings with an earnings forecast score of 7.86 and a high institutional shareholding score of 10, underscoring how heavy planned investments...

Terex stock reacts to strong fundamentals and technical momentum Terex (TEX) has attracted investor attention after reports of significant year-over-year growth in revenue and net profit, alongside high operating efficiency and supportive technical signals that point to strong price momentum. See our latest analysis for Terex. At a share price of $66.82, Terex has seen strong short term momentum, with a 30 day share price return of 16.61% feeding into a 1 year total shareholder return of...

Why ACI Worldwide’s European payments role matters for investors ACI Worldwide (ACIW) has moved closer to the core of Europe’s instant payments push, joining the European Payments Initiative as a principal member and hosting its Wero digital wallet on ACI’s Payments Orchestration Platform. This development sits alongside ACI Worldwide’s existing role in powering instant payment rails across Europe and supporting Rabobank’s planned migration of iDEAL transactions to Wero, tying the company...

Citizens Financial Group, Inc. recently appointed Chris Emerson as Head of Investor Relations, while current IR lead Kristin Silberberg moved to become Chief Financial Officer of the Commercial Bank, as Emerson also retains responsibility for corporate planning and enterprise finance. This leadership reshuffle comes as Citizens reports robust quarterly revenue and profit growth alongside very strong institutional ownership, underscoring how closely investors are watching its financial and...

In April 2026, Becton Dickinson & Company initiated multiple voluntary FDA Class I sub-recalls of BD Spinal Tray devices nationwide after an inspection of supplier Huons Co Ltd. found serious quality deficiencies in anesthetic components. While quantities are relatively modest in unit terms, the recalls touch a wide range of catalog numbers and states, raising questions about quality oversight across Becton Dickinson’s spinal anesthesia tray supply chain. We’ll now examine how these Class I...

Recently, Avient Corp reported stable financial health with year-over-year growth in quarterly revenue and a significant rise in net profit, alongside leading institutional ownership in the Chemicals industry despite a quarter-over-quarter decline in institutional holdings. An interesting angle is that institutional ownership remains above ninety-eight percent, even as Ron Baron marginally increased his stake, underscoring persistent professional investor interest. With this backdrop of...

Recent Share Price Moves and Return Profile ZTO Express (Cayman) (ZTO) has drawn investor attention after recent trading saw the stock close at US$22. Over the past month, the share price declined about 4%, and over the past 3 months it fell roughly 10%. Looking further out, the stock is up about 2.5% year to date and gained roughly 31.8% over the past year. The 3 year and 5 year total returns declined about 4.3% and 19.5% respectively. See our latest analysis for ZTO Express (Cayman). For...

Kennametal earnings jolt investor attention Kennametal (KMT) is back in focus after quarterly revenue rose 21.8% year over year and net profit climbed 84.96%, with both figures surpassing analyst expectations and leading growth among professional tools peers. See our latest analysis for Kennametal. At a share price of $36.32, Kennametal has seen its 1-year total shareholder return of 70.84% outpace its 6.45% 3 month share price return. This suggests stronger performance over the longer term,...

Zoetis (ZTS) is back in focus after a series of securities class action lawsuits accused the company of misleading investors about weakening demand, safety concerns, and market share losses in its key companion animal products. See our latest analysis for Zoetis. At a share price of $78.71, Zoetis has seen pressure build over the past few months, with a 90 day share price return that declined 31.95% and a 1 year total shareholder return that declined 49.14%. Repeated class action...

Earlier this week, Sally Beauty Holdings reported that its latest quarter delivered higher revenue and net profit, supported by strong hair color demand, digital growth, product launches, and cost savings. An interesting twist is that, despite these operational gains and a stable financial health score, analysts’ consensus earnings forecasts have barely moved, hinting at cautious expectations. With optimism building around Sally Beauty’s growth initiatives, we’ll examine how this improved...

Wisconsin regulators have approved WEC Energy Group’s Very Large Customer tariff for new electric loads of 100 megawatts or more, supporting the company’s US$37.50 billion capital plan for 2026–2030 and clarifying how it can recover infrastructure costs from large users. This move effectively shifts WEC Energy Group further toward a regulated growth model, with more predictable cost recovery and lower project risk when serving large industrial and data center customers. We’ll now examine how...

In late May 2026, RBC Capital began covering Black Stone Minerals, L.P. with a Sector Perform rating, citing its 76% gas-weighted asset base and expectations for production growth into 2026, supported by active development across core regions. The firm also highlighted increased natural gas activity in Louisiana and strong oil volumes from the Permian Basin, underscoring how Black Stone’s diversified mineral and royalty interests are being worked by multiple operators to support its current...

Virtu Financial (VIRT) is back in focus after its latest earnings report. Revenue grew by more than 30% year over year and net profit rose 84%, drawing fresh attention to the stock’s efficiency and valuation. See our latest analysis for Virtu Financial. Those results have arrived alongside strong momentum in Virtu Financial’s stock, with a 1 month share price return of 19.56% and a year to date share price return of 93.47%. The 3 year total shareholder return of 293.06% points to a longer...

Unum Group (UNM) recently outlined its growth priorities at the Morgan Stanley US Financials Conference in New York. The company highlighted premium trends, disability claims experience, and capital allocation, along with technology and operational investments. See our latest analysis for Unum Group. The recent Morgan Stanley US Financials Conference presentation comes after a strong run in Unum Group’s stock, with a 90-day share price return of 24.08% and a five year total shareholder return...

SLB (SLB) is under investor scrutiny after recent share price softness, with the stock down about 4% over the past day, 14% over the past week, and 16% over the past month. See our latest analysis for SLB. Despite the recent pullback, with the 30 day share price return down 16% and the 7 day move also weaker, SLB still shows a 19.63% year to date share price return and a 37.84% total shareholder return over one year. This signals that momentum has cooled in the very short term but remains...

Earlier this month, Gilead Sciences reported that the FDA accepted its supplemental New Drug Application for Yeztugo (lenacapavir) 300‑mg tablets as a potential once‑weekly oral HIV PrEP option, with a Prescription Drug User Fee Act decision date set for February 2, 2027. The filing, backed by PURPOSE 1 and PURPOSE 2 trial data and aiming to introduce the first long‑acting oral PrEP, highlights how Gilead is seeking to broaden HIV prevention choices beyond its existing every‑six‑month...

Earlier in June 2026, Savara Inc. stockholders approved doubling the company’s authorized common shares to 600,000,000, while Chief Financial Officer and Chief Administrative Officer Dave Lowrance announced his departure for health-related reasons effective July 15, 2026. Chief Operating Officer Robert Lutz will also assume the Chief Financial Officer role, concentrating operational and financial leadership in a single executive with extensive pharmaceutical industry experience. We’ll now...

Immunovant (IMVT) is back in focus after reporting a wider than expected quarterly loss tied to IMVT-1402 development and batoclimab discontinuation costs, along with updates on its Graves' Disease and CIDP programs. See our latest analysis for Immunovant. Against that backdrop, Immunovant’s share price has risen strongly, with a 90 day share price return of 53.79% and a 1 year total shareholder return of 123.67%, signaling firm momentum as investors weigh its IMVT-1402 and CIDP updates. If...

Danaos (DAC) has drawn fresh attention after recent trading left the stock down about 5% over the past month, even as its total return over the past 3 months stands near 13%. See our latest analysis for Danaos. Against that backdrop, Danaos’s share price has eased around 4% over the past week and 5% over the past month. However, the 90 day share price return of about 13% and 1 year total shareholder return close to 49% point to momentum that has cooled recently rather than fully reversed. If...

Global markets are absorbing fresh economic data and new regulatory rules, and that mix is quietly reshaping where risk and resilience sit in many portfolios. Large, well capitalised companies that already operate under tight rules can sometimes turn regulatory complexity into a competitive advantage, while others face tougher headwinds. This article looks at three regulation resilient blue chip stocks that are closely exposed to the latest macro and policy shifts, and explains why some...

Academy Sports and Outdoors, Inc. recently reported first-quarter 2026 results, with sales rising to US$1,442 million and net income increasing to US$52.7 million, lifting both basic and diluted earnings per share from continuing operations compared with a year earlier. This earnings improvement, built on higher revenue and profitability, offers fresh evidence of operational progress that could influence how investors view the company’s longer-term earnings profile. With first-quarter sales...